Chromosome 5q Deletion Syndrome (MAR)

Alias:

5q- Syndrome

Myelodysplastic Syndrome Associated with Isolated Del Chromosome Abnormality

Macrocytic Anemia, Refractory, Due to 5q Deletion, Somatic

Myelodysplastic Syndrome with Isolated Del

Mar

5q- Syndrome, Refractory Macrocytic Anemia Due to 5q Deletion

Anemia, Macrocytic, Refractory, Due to 5q Deletion, Somatic

Myelodysplastic Syndrome with 5q Deletion Syndrome

Macrocytic Anemia, Refractory, Due to 5q Deletion

Refractory Macrocytic Anemia Due to 5q Deletion

Myelodysplastic Syndrome with 5q Deletion

Chromosome 5, Trisomy 5q

Chromosome 5q Deletion

Loss of Chromosome 5q

5q Minus Syndrome

5 Q- Syndrome

5q-Syndrome

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Chromosome 5q Deletion Syndrome, also known as 5q- syndrome, is related to macrocytic anemia and leukemia, acute myeloid. An important gene associated with Chromosome 5q Deletion Syndrome is RPS14 (Ribosomal Protein S14), and among its related pathways/superpathways are Influenza Infection and SARS-CoV-1-host interactions. The drugs Tacrolimus and Methotrexate have been mentioned in the context of this disorder. Affiliated tissues include bone marrow and myeloid, and related phenotypes are myelodysplasia and macrocytic anemia

Related ID：

MALACARDS：CHR635

OMIM：153550

MESH：C535323

ICD11：420472577